Literature DB >> 3106758

Endometrium and plasma hormone profile in the peri-menopause and post-menopause.

R Trévoux, J De Brux, M Castanier, K Nahoul, J P Soule, R Scholler.   

Abstract

Endometrial histology and plasma levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), 17 beta-oestradiol (E2), oestrone (E1) and progesterone (P) were studied in 483 women over a period of 13 yr (6 yr before and 7 yr after the start of definitive amenorrhoea, defined as the last menstrual bleeding). The patterns for these parameters were established on the basis of the results of 1227 gonadotrophin and steroid determinations and 721 endometrial biopsies. Three periods were identified. During the first, from year-6 to year-3, gonadotrophin levels increased gradually, while those of E2 remained normal, with peaks in some cases. Mean plasma P levels were within the normal range until year-3, but they then decreased progressively. Endometrial histology was similar to that observed during reproductive life. In the second period, from year-3 to year+1, there was a concomitant rise in gonadotrophins as the E2 and P levels decreased. However, at the start of definitive amenorrhoea, the mean E2 and P levels fluctuated between 60 and 100 pg/ml and between 2 and 3 ng/ml, respectively. The endometrium reflected this decrease in E2 and P production. It was not atrophic but proliferative when definitive amenorrhoea commenced. During the last period, from year+1 to year+7, gonadotrophins reached a plateau at high levels, while those of E2 continued to fall, reaching very low values at year+4, after which they reached a plateau. P levels were at the detection limit of the technique. The correlations between all plasma steroid levels and endometrial histology demonstrated discrepancies in 30% of cases: proliferative or hyperplastic endometria were seen at E2 levels of under 60 mg/ml, atrophic endometric at E2 levels of over 60 pg/ml and secretory endometria at very low P levels.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3106758     DOI: 10.1016/0378-5122(86)90039-3

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  8 in total

Review 1.  Aging, estrogens, and episodic memory in women.

Authors:  Victor W Henderson
Journal:  Cogn Behav Neurol       Date:  2009-12       Impact factor: 1.600

2.  G-protein coupled estrogen receptor, estrogen receptor α, and progesterone receptor immunohistochemistry in the hypothalamus of aging female rhesus macaques given long-term estradiol treatment.

Authors:  Michelle M Naugle; Long T Nguyen; Tyler K Merceron; Edward Filardo; William G M Janssen; John H Morrison; Peter R Rapp; Andrea C Gore
Journal:  J Exp Zool A Ecol Genet Physiol       Date:  2014-05-24

Review 3.  The timing of the age at which natural menopause occurs.

Authors:  Ellen B Gold
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

4.  Genetic polymorphisms, hormone levels, and hot flashes in midlife women.

Authors:  Chrissy Schilling; Lisa Gallicchio; Susan R Miller; Patricia Langenberg; Howard Zacur; Jodi A Flaws
Journal:  Maturitas       Date:  2006-12-21       Impact factor: 4.342

5.  Uterine estrogen sulfatase may play a more important role than the hepatic sulfatase in mediating the uterotropic action of estrone-3-sulfate.

Authors:  B T Zhu; J H Fu
Journal:  Endocrine       Date:  1997-10       Impact factor: 3.633

Review 6.  Progestogens' effects and mechanisms for object recognition memory across the lifespan.

Authors:  Alicia A Walf; Carolyn J Koonce; Cheryl A Frye
Journal:  Behav Brain Res       Date:  2015-07-30       Impact factor: 3.332

Review 7.  The Impact of Menstrual Cycle Phase on Athletes' Performance: A Narrative Review.

Authors:  Mikaeli Anne Carmichael; Rebecca Louise Thomson; Lisa Jane Moran; Thomas Philip Wycherley
Journal:  Int J Environ Res Public Health       Date:  2021-02-09       Impact factor: 4.614

8.  Age-dependent sex differences in calcium and phosphate homeostasis.

Authors:  W N H Koek; N Campos-Obando; B C J van der Eerden; Y B de Rijke; M A Ikram; A G Uitterlinden; J P T M van Leeuwen; M C Zillikens
Journal:  Endocr Connect       Date:  2021-03       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.